Breast cancer imaging with radiolabelled peptide from complementarity-determining region of antitumour antibody
- 1 December 1995
- journal article
- Published by Elsevier in The Lancet
- Vol. 346 (8991-8992) , 1662-1666
- https://doi.org/10.1016/s0140-6736(95)92839-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Tumour localisation with 131I-labelled human IgM monoclonal antibody 16.88 in advanced colorectal cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1991
- Tumour localisation with a radioactively labelled reshaped human monoclonal antibodyBritish Journal of Cancer, 1991
- Lymphoscintigraphy with 13I-labelled epidermal growth factorThe Lancet, 1991
- Monoclonal antibodies for imaging and therapyBritish Journal of Cancer, 1989
- LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATINThe Lancet, 1989
- Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.Proceedings of the National Academy of Sciences, 1988
- The human tumour-associated epithelial mucins are coded by an expressed hypervariable gene locus PUMNature, 1987
- Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3International Journal of Cancer, 1987
- Radiolabeling of monoclonal antibody against carcinoembryonic antigen with 88Y and biodistribution studiesInternational Journal of Nuclear Medicine and Biology, 1985
- Production of functional chimaeric mouse/human antibodyNature, 1984